Pharmaceuticals, Biotechnology and Life Sciences
– After Median Follow-Up of 11.5 Months, 73 Percent of Patients Had Confirmed Tumor Response with Majority of Responses Still…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Beam Therapeutics Inc. (Nasdaq:BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the closing…
SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences Inc. (“ZYUS”), a company focused on the global development and commercialization of innovative cannabinoid-based formulations,…
MINNEAPOLIS–(BUSINESS WIRE)–DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biotechnology company, announced today the pricing of an underwritten registered public offering…
DUBLIN–(BUSINESS WIRE)–The “Heart Failure: Global Drug Forecast and Market Analysis to 2028” report has been added to ResearchAndMarkets.com’s offering. Summary…
– Fourth-Quarter Revenue of $691.1 Million and Full-Year Revenue of $2.62 Billion – – Fourth-Quarter GAAP Earnings per Share of…
Program Aims to Improve Overall Survival in Advanced-Stage Cancers BOULDER, Colo.–(BUSINESS WIRE)–Biodesix, Inc. announced initiation of the next phase of…
NEW YORK–(BUSINESS WIRE)–Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ solutions as prescription medical treatments, today announced the appointments…
Company Continues Progress on Reducing Carbon Footprint LONDON–(BUSINESS WIRE)–Walgreens Boots Alliance (Nasdaq: WBA) today announced the publication of its 2019…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the…